Mackenzie Financial’s SpringWorks Therapeutics SWTX Stock Holding History

Mackenzie Financial’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,408	Closed	-$207K	–	1838
2025 Q2	$207K	Buy	+4,408	New	+$196K	﹤0.01%	1546
2024 Q2	–	Sell	-4,137	Closed	-$204K	–	1622
2024 Q1	$204K	Buy	+4,137	New	+$191K	﹤0.01%	1340

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Mackenzie Financial's SWTX Position: Q3 2025 in Review

Mackenzie Financial sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 4,408 shares — an estimated $207K sold.

Mackenzie Financial first reported a position in SWTX in Q1 2024 and held it in 2 quarters. The position peaked at $207K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Mackenzie Financial reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Mackenzie Financial sold 4,408 SpringWorks Therapeutics shares in Q3 2025, an estimated $207K.
Mackenzie Financial first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 2 quarters.
Mackenzie Financial's SpringWorks Therapeutics position peaked at $207K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Mackenzie Financial's 13F filing for Q3 2025, filed 13 Nov 2025.